{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T04:56:02Z","timestamp":1764046562156},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,9,1]]},"DOI":"10.1093\/jjco\/hyw093","type":"journal-article","created":{"date-parts":[[2016,7,6]],"date-time":"2016-07-06T02:19:12Z","timestamp":1467771552000},"page":"856-861","source":"Crossref","is-referenced-by-count":5,"title":["A retrospective study of treatment and prophylaxis of ifosfamide-induced hemorrhagic cystitis in pediatric and adolescent and young adult (AYA) patients with solid tumors"],"prefix":"10.1093","volume":"46","author":[{"given":"Yoshimasa","family":"Saito","sequence":"first","affiliation":[{"name":"Department of Pharmacy, National Cancer Center Hospital, Tokyo"},{"name":"Faculty of Pharmaceutical Sciences, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Kumamoto","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology, National Cancer Center Hospital, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinori","family":"Makino","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, National Cancer Center Hospital, Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ikumi","family":"Tamai","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chitose","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology, National Cancer Center Hospital, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Terakado","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, National Cancer Center Hospital, Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2016,8,31]]},"reference":[{"key":"key\n\t\t\t\t2018111508255290900_hyw093C1","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0277-5379(81)80019-3","article-title":"Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention. 2. Comparative study on the uroprotective efficacy of thiols and other sulfur compounds","volume":"17","author":"Brock","year":"1981","journal-title":"Eur J Cancer Clin Oncol"},{"key":"key\n\t\t\t\t2018111508255290900_hyw093C2","doi-asserted-by":"crossref","first-page":"428","DOI":"10.2165\/00003495-199142030-00006","article-title":"Ifosfamide\/mesna. A review of its antineoplastic activity, pharmacokinetic properties and therapeutic efficacy in cancer","volume":"42","author":"Dechant","year":"1991","journal-title":"Drugs"},{"key":"key\n\t\t\t\t2018111508255290900_hyw093C3","first-page":"1311","article-title":"The analysis of ifosfamide and its metabolites (review)","volume":"13","author":"Kaijser","year":"1993","journal-title":"Anticancer Res"},{"key":"key\n\t\t\t\t2018111508255290900_hyw093C4","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s10565-006-0078-0","article-title":"Pathophysiological aspects of cyclophosphamide and ifosfamide induced hemorrhagic cystitis: implication of reactive oxygen and nitrogen species as well as PARP activation","volume":"23","author":"Korkmaz","year":"2007","journal-title":"Cell Biol Toxicol"},{"key":"key\n\t\t\t\t2018111508255290900_hyw093C5","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/BF00410691","article-title":"Detoxification of urotoxic oxazaphosphorines by sulfhydryl compounds","volume":"100","author":"Brock","year":"1981","journal-title":"J Cancer Res Clin Oncol"},{"key":"key\n\t\t\t\t2018111508255290900_hyw093C6","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/BF01612769","article-title":"Placebo-controlled double-blind comparative study on the preventive efficacy of mesna against ifosfamide-induced urinary disorders","volume":"117","author":"Fukuoka","year":"1991","journal-title":"J Cancer Res Clin Oncol"},{"key":"key\n\t\t\t\t2018111508255290900_hyw093C7","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1200\/JCO.2008.17.2627","article-title":"American Society of Clinical Oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectants","volume":"27","author":"Hensley","year":"2009","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t2018111508255290900_hyw093C8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0305-7372(85)90011-8","article-title":"Ifosfamide \u2013 pharmacology, safety and therapeutic potential","volume":"12","author":"Brade","year":"1985","journal-title":"Cancer Treat Rev"},{"key":"key\n\t\t\t\t2018111508255290900_hyw093C9","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1200\/JCO.1999.17.10.3333","article-title":"American Society of Clinical Oncology clinical practice guidelines for the use of chemotherapy and radiotherapy protectants","volume":"17","author":"Hensley","year":"1999","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t2018111508255290900_hyw093C10","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1097\/01.ju.0000063640.41307.c9","article-title":"Treatment of radiation induced hemorrhagic cystitis with hyperbaric oxygen","volume":"169","author":"Corman","year":"2003","journal-title":"J Urol"},{"key":"key\n\t\t\t\t2018111508255290900_hyw093C11","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1399-0012.2007.00705.x","article-title":"Hemorrhagic cystitis: a retrospective single-center survey","volume":"21","author":"Hassan","year":"2007","journal-title":"Clin Transplant"},{"key":"key\n\t\t\t\t2018111508255290900_hyw093C12","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.juro.2013.08.007","article-title":"Risk factors and predictors of severity score and complications of pediatric hemorrhagic cystitis","volume":"191","author":"Riachy","year":"2014","journal-title":"J Urol"},{"key":"key\n\t\t\t\t2018111508255290900_hyw093C13","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/0090-4295(82)90633-1","article-title":"Prevention of cyclophosphamide-induced hemorrhagic cystitis","volume":"20","author":"Droller","year":"1982","journal-title":"Urology"},{"key":"key\n\t\t\t\t2018111508255290900_hyw093C14","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","article-title":"Revised equations for estimated GFR from serum creatinine in Japan","volume":"53","author":"Matsuo","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"key\n\t\t\t\t2018111508255290900_hyw093C15","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0031-3955(16)36251-4","article-title":"The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents","volume":"34","author":"Schwartz","year":"1987","journal-title":"Pediatr Clin North Am"},{"key":"key\n\t\t\t\t2018111508255290900_hyw093C16","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJM198710223171717","article-title":"Simplified calculation of body-surface area","volume":"317","author":"Mosteller","year":"1987","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2018111508255290900_hyw093C17","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jpurol.2009.02.199","article-title":"Pediatric hemorrhagic cystitis","volume":"5","author":"Decker","year":"2009","journal-title":"J Pediatr Urol"},{"key":"key\n\t\t\t\t2018111508255290900_hyw093C18","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.juro.2012.03.020","article-title":"Intractable hemorrhagic cystitis after hematopoietic stem cell tranplantation \u2013 is there a role for early urinary diversion in children","volume":"188","author":"Lukasewycz","year":"2012","journal-title":"J Urol"},{"key":"key\n\t\t\t\t2018111508255290900_hyw093C19","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/BF01612769","article-title":"Placebo-controlled double-blind comparative study on the preventive efficacy of mesna against ifosfamide-induced urinary disorders","volume":"117","author":"Fukuoka","year":"1991","journal-title":"J Cancer Res Clin Oncol"},{"key":"key\n\t\t\t\t2018111508255290900_hyw093C20","first-page":"451","article-title":"Studies on the human pharmacokinetics of isophosphamide (NSC-109724)","volume":"60","author":"Allen","year":"1976","journal-title":"Cancer Treat Rep"},{"key":"key\n\t\t\t\t2018111508255290900_hyw093C21","first-page":"2313","article-title":"Similar bioavailability of single-dose oral and intravenous mesna in the blood and urine of healthy human subjects","volume":"4","author":"Goren","year":"1998","journal-title":"Clin Cancer Res"},{"key":"key\n\t\t\t\t2018111508255290900_hyw093C22","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0022-5347(17)49330-X","article-title":"Intravesical irrigation with alum for the control of massive bladder hemorrhage","volume":"133","author":"Goel","year":"1985","journal-title":"J Urol"},{"key":"key\n\t\t\t\t2018111508255290900_hyw093C23","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/S0022-5347(17)44907-X","article-title":"An unusual complication of silver nitrate treatment of hemorrhagic cystitis: case report","volume":"136","author":"Jerkins","year":"1986","journal-title":"J Urol"},{"key":"key\n\t\t\t\t2018111508255290900_hyw093C24","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0022-5347(17)41016-0","article-title":"Intravesical formalin for hemorrhagic cystitis: analysis of therapy","volume":"141","author":"Donahue","year":"1989","journal-title":"J Urol"},{"key":"key\n\t\t\t\t2018111508255290900_hyw093C25","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0090-4295(99)80349-5","article-title":"Intravesicular carboprost for the treatment of hemorrhagic cystitis after marrow transplantation","volume":"46","author":"Ippoliti","year":"1995","journal-title":"Urology"},{"key":"key\n\t\t\t\t2018111508255290900_hyw093C26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-5347(17)39848-8","article-title":"Hemorrhagic cystitis: a review","volume":"143","author":"deVries","year":"1990","journal-title":"J Urol"}],"container-title":["Japanese Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jjco\/article-pdf\/46\/9\/856\/26576299\/hyw093.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T19:20:50Z","timestamp":1568143250000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jjco\/article\/46\/9\/856\/2218813"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,31]]},"references-count":26,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2016,8,31]]},"published-print":{"date-parts":[[2016,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jjco\/hyw093","relation":{},"ISSN":["1465-3621","0368-2811"],"issn-type":[{"value":"1465-3621","type":"electronic"},{"value":"0368-2811","type":"print"}],"subject":[],"published-other":{"date-parts":[[2016,9]]},"published":{"date-parts":[[2016,8,31]]}}}